Nano-H

Pioneer company of nanohybrids for industrial applications Bridge between labs, clinical trials, and industry, we ensure innovation reaches its full potential Nano-H, founded in December 2004 by Lyon university researchers, specializes in developing innovative technologies for new materials based on hybrid nanoparticles. The company focuses on functional nanomaterials for optics and tracers, nanomaterials for biological applications, particularly nanodrugs, and chitosan-based hydrogels for biomedical use. Additionally, Nano-H leverages AI to analyze multimineral profiles for innovative diagnostic and prognostic purposes. Nano-H developed the first hybrid organic/inorganic theranostic drug, AGuIX